The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Factors associated with Type I and Type II endometrial cancer
Open accessAbstract
ObjectiveWe investigated risk factors for Type II (n = 176) vs. Type I (n = 1,576) endometrial cancer (EC) in cases treated at Magee-Womens Hospital between 1996 and 2008.MethodsClinical data were available from the University of Pittsburgh Medical Center (UPMC) Network Cancer Registry. Logistic regression was used to estimate the adjusted odds of having Type II EC vs. Type I EC. Risk factors of interest in this analysis were age, race, body mass index (BMI), year of diagnosis, parity, menopausal status, and history of additional primary tumors.ResultsRelative to women with Type I EC, women with Type II EC were more likely to be older at diagnosis (OR: 1.03 per 1 year increase in age, 95% CI 1.01–1.05), of non-white race (OR: 2.95, 95% CI 1.66–5.27), have a history of additional primary tumors (OR: 1.56, 95% CI 1.05–2.32), and less likely to be obese (OR: 0.45, 95% CI 0.29–0.70).ConclusionIn this large retrospective cohort of patients with EC, the striking difference in risk factors associated with Type II vs. Type I tumors suggests that these subtypes represent different disease entities that require different treatment modalities. Currently, Type II cases have a significantly worse prognosis compared to Type I. Further characterization of risk factors associated with developing Type II tumors is needed to prevent this aggressive malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Two pathogenetic types of endometrial carcinoma
Bokhman, J. V. (1983) · Gynecologic Oncology · doi:10.1016/0090-8258(83)90111-7 · Cited by 2,494
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Kaaks, R., Lukanova, A., & Kurzer, M. S. (2002) · PubMed · Cited by 1,181
Textbook of Cancer Epidemiology
(2008) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195311174.001.0001 · Cited by 713
Hamilton, C. A., Cheung, M. K., Osann, K., Chen, L., Teng, N. N., Longacre, T. A., Powell, M. A., Hendrickson, M. R., Kapp, D. S., & Chan, J. K. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603012 · Cited by 644
Sherman, M. E., Bur, M. E., & Kurman, R. J. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90204-x · Cited by 342
Boruta, D. M., Gehrig, P. A., Fader, A. N., & Olawaiye, A. B. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.06.011 · Cited by 254
Novel molecular profiles of endometrial cancer—new light through old windows
Doll, A., Abal, M., Rigau, M., Monge, M., Gonzalez, M., Demajo, S., Colás, E., Llauradó, M., Alazzouzi, H., Planagumá, J., et al. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.020 · Cited by 212
Cirisano, F. D., Robboy, S. J., Dodge, R. K., Bentley, R. C., Krigman, H. R., Synan, I. S., Soper, J. T., & Clarke-Pearson, D. L. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5505 · Cited by 199
Sorosky, J. I. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318162f690 · Cited by 175
Soslow, R. A., Bissonnette, J. P., Wilton, A., Ferguson, S. E., Alektiar, K. M., Duska, L. R., & Oliva, E. (2007) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31802ee494 · Cited by 166
Body size in relation to cancer of the uterine corpus in 1 million Norwegian women
Bjørge, T., Engeland, A., Tretli, S., & Weiderpass, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22260 · Cited by 158
Benign Endometrial Hyperplasia Sequence and Endometrial Intraepithelial Neoplasia
Mutter, G. L., Zaino, R. J., Baak, J. P. A., et al. (2007) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31802e4696 · Cited by 153
Ryan, A. J., Susil, B. J., Jobling, T. W., & Oehler, M. K. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1109-5 · Cited by 150
Uterine serous and grade 3 endometrioid carcinomas: Is there a survival difference?
Boruta, D. M., Gehrig, P. A., Groben, P. A., Bae-Jump, V. L., Boggess, J. F., Fowler, W. C., & Le, L. V. (2004) · Cancer · doi:10.1002/cncr.20645 · Cited by 137
Non-Endometrioid Adenocarcinoma of the Uterine Corpus: A Review of Selected Histological Subtypes
Mendivil, A. A., Schuler, K., & Gehrig, P. A. (2009) · Cancer Control · doi:10.1177/107327480901600107 · Cited by 133
Epplein, M., Reed, S. D., Voigt, L. F., Newton, K. M., Holt, V. L., & Weiss, N. S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn168 · Cited by 130
Lacey, J. V., Mutter, G. L., Nucci, M. R., Ronnett, B. M., Ioffe, O. B., Rush, B. B., Glass, A. G., Richesson, D. A., Chatterjee, N., Langholz, B. M., et al. (2008) · Cancer · doi:10.1002/cncr.23808 · Cited by 85
Petignat, P., Usel, M., Gauthier, P., Popowski, Y., Pelte, M. F., Bouchardy, C., & Verkooijen, H. (2008) · PubMed · Cited by 13
Factors Influencing Endometrial Cancer Mortality: The Western Pennsylvania Registry
Linkov, F. Y., & Taioli, E. (2008) · Future Oncology · doi:10.2217/14796694.4.6.857 · Cited by 9
Self-citationWajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4
Cited by
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Setiawan, V. W., Yang, H. P., Pike, M. C., McCann, S. E., Yu, H., Xiang, Y.-B., Wolk, A., Wentzensen, N., Weiss, N. S., Webb, P. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.2596 · Cited by 827
Makker, V., MacKay, H., Ray-Coquard, I., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00324-8 · Cited by 674
Clinical actionability of molecular targets in endometrial cancer
Urick, M. E., & Bell, D. W. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0177-x · Cited by 405
USA endometrial cancer projections to 2030: should we be concerned?
Sheikh, M. A., Althouse, A. D., Freese, K. E., Soisson, S., Edwards, R. P., Welburn, S., Sukumvanich, P., Comerci, J., Kelley, J., LaPorte, R. E., et al. (2014) · Future Oncology · doi:10.2217/fon.14.192 · Cited by 236
Self-citationJamison, P. M., Noone, A.-M., Ries, L. A. G., Lee, N. C., & Edwards, B. K. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0996 · Cited by 101
Metadata
- Authors
- Felix, A. S., Weissfeld, J. L., Stone, R. A., Bowser, R., Chivukula, M., Edwards, R. P., & Linkov, F.
- Venue
- Cancer Causes & Control
- Published
- 2010-07-14
- Volume
- 21
- Issue
- 11
- Pages
- 1851-1856
- ISSN
- 0957-5243 (ISSN-L)
- 1573-7225
- OpenAlex
- W1994381471
- Cited by
- 284
- References
- 22
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.